Pure Global
NCT05963152

Resistance Exercise and Cognition in People With Type 1 Diabetes

The Effects of Resistance Exercise on Cognition in People With Type 1 Diabetes: a Randomised Controlled Trial
Dasman Diabetes Institute·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
type1diabetes
Drug/Device/Intervention
Habitual Physical Activity
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Dasman Diabetes Institute
Location
Kuwait City, Kuwait
Timeline & enrollment
Phase
N/A
Start date
Jul 20, 2023
End date
Aug 01, 2024
Enrollment
54 participants
Primary outcome

Chronic change in Paced Auditory Serial Addition Test (PASAT) score,Chronic change in Colour Trails Test score

Summary

The aim of the current study is to determine the effects of resistance exercise on
 performance of the Paced Auditory Serial Addition Test and the Colour Trails Test.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05963152
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05963152 through Pure Global AI's free database. This phase not specified trial is sponsored by Dasman Diabetes Institute and is currently Recruiting. The study focuses on type1diabetes. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.